Literature DB >> 6739783

Subpleural fat pads in patients exposed to asbestos: distinction from non-calcified pleural plaques.

E N Sargent, W D Boswell, P W Ralls, A Markovitz.   

Abstract

Thirty patients with known asbestos dust exposure were studied because of uncertainty as to whether or not the pleural changes observed on the radiographs were due to plaques or subpleural fat. The CT scans confirmed that the changes were due to subpleural fat in 14 cases (48%). Characteristic subpleural fat shadows on radiographs and CT scans are described, and the importance of differentiating fat from plaques for medico-legal reasons is emphasized.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6739783     DOI： 10.1148/radiology.152.2.6739783

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  4 in total

1.  Development, radiological zone patterns, and importance of diffuse pleural thickening in relation to occupational exposure to asbestos.

Authors:  H Bohlig; A Calavrezos
Journal:  Br J Ind Med       Date:  1987-10

2.  Pleural thickening: a comparison of oblique chest radiographs and high-resolution computed tomography in subjects exposed to low levels of asbestos pollution.

Authors:  J Ameille; P Brochard; J M Brechot; T Pascano; A Cherin; A Raix; M Fredy; J Bignon
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

3.  Restrictive lung function and asbestos-induced pleural fibrosis. A quantitative approach.

Authors:  D A Schwartz; J R Galvin; S J Yagla; S B Speakman; J A Merchant; G W Hunninghake
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

4.  Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA.

Authors:  Lucy A Peipins; Michael Lewin; Sharon Campolucci; Jeffrey A Lybarger; Aubrey Miller; Dan Middleton; Christopher Weis; Michael Spence; Brad Black; Vikas Kapil
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.